Mumbai, June 4 (Udaipur Kiran): Granules India is currently trading at Rs. 791.05, up by 14.20 points or 1.83% from its previous closing of Rs. 776.85 on the BSE. The scrip opened at Rs. 780.70 and has touched a high and low of Rs. 793.45 and Rs. 779.95 respectively. So far 515872 shares were traded […]
Mumbai, June 3 (Udaipur Kiran): Concord Biotech is currently trading at Rs. 1231.00, up by 64.20 points or 5.50% from its previous closing of Rs. 1166.80 on the BSE. The scrip opened at Rs. 1235.00 and has touched a high and low of Rs. 1264.45 and Rs. 1194.00 respectively. So far 126043 shares were traded […]
Mumbai, May 14 (Udaipur Kiran): Lupin is currently trading at Rs. 2248.35, up by 32.90 points or 1.49% from its previous closing of Rs. 2215.45 on the BSE. The scrip opened at Rs. 2253.85 and has touched a high and low of Rs. 2,255.45 and Rs. 2,240.00 respectively. So far 284 shares were traded on […]
Mumbai, February 11 (Udaipur Kiran): Cipla is currently trading at Rs. 1347.65, up by 5.55 points or 0.41% from its previous closing of Rs. 1342.10 on the BSE. The scrip opened at Rs. 1348.20 and has touched a high and low of Rs. 1350.00 and Rs. 1335.00 respectively. So far 29185 shares were traded on […]
Mumbai, December 2 (Udaipur Kiran): Wockhardt was trading sharply higher at Rs. 1,504.25 on the BSE, up by 33.35 points or 2.27 per cent from its previous close of Rs. 1,470.90. The stock opened at Rs. 1,492.95 and moved between a high of Rs. 1,566.95 and a low of Rs. 1,467.80 during the session. So […]
Mumbai, November 27 (Udaipur Kiran): Shares of Glenmark Pharmaceuticals were trading higher on the BSE after the company received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the United States Food & Drug Administration (USFDA) for its manufacturing facility in the USA. The stock was trading at Rs. 1,941.90, up […]
Mumbai, 13 November (Udaipur Kiran)। Shares of Lupin edged higher on Thursday after the company announced it has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its Chhatrapati Sambhajinagar (Aurangabad) facility. The EIR follows a product-specific Pre-Approval Inspection (PAI) conducted by the USFDA between September 1–5, 2025. Lupin’s […]
